The cytochemical changes and the adherence of neutrophil during cross-linked agarose encapsulated activated charcoal hemoperfusion.

After one hour cross-linked agarose encapsulated activated charcoal hemoperfusion, there was slight increase of total white cells and neutrophil count, but the neutrophil adherence was 16.87 +/- 5.26% and marked lower than that before hemoperfusion (59.91 +/- 5.26%, p less than 0.05). Using glassball hemoperfusion as control, the neutrophil adherence also decreased but not so obvious as the former. Adherence is a cell property that may affect granulocyte margination, diapedesis, chemotaxis and phagocytic function, so the above investigations showed that both the hemoperfusion process and the charcoal itself may reduce the host defence mechanism. There were no change of the peroxidase and alkaline phosphatase activities of neutrophils during one hour cross-linked agarose encapsulated activated charcoal hemoperfusion.

Effect of hemoperfusion of cross-linked agarose coated activated charcoal (CAAC-II) on T-lymphocyte function in rats and guinea pigs.

Blood of rats and guinea pigs on cross-linked agarose coated activated charcoal (CAAC-II) hemoperfusion was analyzed over a follow-up period of 48 hours for the capacity of T-lymphocyte to transform under the stimulation of mitogen (PHA) in vivo and in vitro respectively. In the rate hemoperfusion, the in vivo T-lymphocyte transformation and lymphocyte count of peripheral blood were involved. In guinea pigs, the lymphocyte cultures were labelled with 3H-TdR and the radioactive incorporation was measured on the liquid scintillation counter. Our results revealed that the T-lymphocyte transformation function remained unchanged after 60-minute CAAC-II hemoperfusion although there was a transient and incomplete suppression of the T-lymphocyte transformation function both in vivo and in vitro immediately after the anesthesia and operation with blood vessel cannulation. The peripheral blood lymphocyte count also remained stable during the 60-minute CAAC-II hemoperfusion on rats and guinea pigs. We concluded that the charcoal hemoperfusion can be used as an important method of treatment for drug intoxication, uremia and hepatic coma with no harm to the body's immune function.

In vitro in vivo studies on removal of middle molecules by macroporous resins.

Various types of macroporous resin beads were screened for the adsorption of middle molecules in vitro. In order to obtain high adsorption capacity, the pore size of the resin should be large enough to allow diffusion of the middle molecules. The adsorption capacity of X-5 resin for Vitamin B12, inulin and cytochrome C was 35.3 mg/g, 1.2 mg/g and 42.9 mg/g respectively in vitro tests. Hemoperfusion with acute renal failure rat model showed good clearance (0.35 +/- 0.25) with X-5 resin for middle molecules.

Middle molecules in the serum, brain, liver and urine of galactosamine-induced fulminant hepatic failure rats.

The middle-molecular weight compounds in the serum, liver, brain and urine were determined in normal and galactosamine-induced grade III coma fulminant hepatic failure (FHF) rats. Peak 7 and subpeak 7g middle molecules increased significantly in the serum of hepatic coma rats. In the brain of grade III coma FHF rats, subpeak 7g increased significantly but peak 7 and other subpeaks decreased significantly. In the liver and urine, both peak 7 and subpeak 7g decreased significantly in grade III coma FHF rats. This rather specific increase of subpeak 7g in the brain corresponding to the increase of subpeak 7g in the serum may contribute to further understanding of the role of middle molecules in hepatic coma.

Tyrosinase immobilized within artificial cells for detoxification in liver failure: II. In vivo studies in fulminant hepatic failure rats.

Galactosamine-induced fulminant hepatic failure rats were used for in vivo studies of the removal of tyrosine and total free phenol by means of hemoperfusion over immobilized tyrosinase within artificial cells. The elevated plasma tyrosine level was decreased to about half the value after one hour of hemoperfusion. The studies of tyrosine clearance suggest that it is efficient and remains constant throughout the one-hour hemoperfusion. In those galactosamine-induced fulminant hepatic failure rats with increased total free phenol levels hemoperfusion over tyrosinase artificial cells significantly lowered the level.

Tyrosinase immobilized within artificial cells for detoxification in liver failure: I. preparation and in vitro studies.

The in vitro removal of tyrosine by means of perfusion over immobilized tyrosinase within artificial cells was studied. The assayed activity of the microencapsulated tyrosinase was about half the value of the same amount of enzyme in free solution. Further studies were conducted to determine the stability, kinetics, and clearance of this system. The results obtained suggest that immobilized tyrosinase within artificial cells is efficient in removing tyrosine in vitro and further study in an animal model is feasible.